Skip to main content
. 2013 May;51(5):1534–1540. doi: 10.1128/JCM.00103-13

Table 2.

Estimated serum drug concentrations that led to TTD delays of ≥3 ha

Drugb Peak serum drug concn (mg/liter) Microorganism/bottle type Serum drug concn (mg/liter) causing ≥3-h delay 95% CI (mg/liter)
AMC 11.6 MSSA/FA 1 1–2
MSSA/FN 6 3–42
MRSA/FA 21 12–98
MRSA/FN 55 46–70
S. epidermidis/FA 0.4 0.39–0.41
S. epidermidis/FN 2 1–5
K. pneumoniae KP2/FA 15 11–21
K. pneumoniae KP2/FN 15 22–158
CTX 214.1 K. pneumoniae KP1/FA 204 182–233
K. pneumoniae KP1/FN 89 61–167
CIP 4.6 MSSA/FA 191 96–380
S. pneumoniae SP2/FN 58 35–178
P. aeruginosa/FA 39 29–61
P. aeruginosa/FN 22 18–27
E. coli/FA 6 6–7
E. coli/FN 4 3–5
K. pneumoniae KP2/FA 3 3–3
K. pneumoniae KP2/FN 2 1–5
FLC 6.72 C. albicans/FN 249 151–704
GEN 7.6 S. epidermidis/FA 43 34–57
S. epidermidis/FN 27 21–38
E. coli/FA 251 126–500
E. coli/FN 146 73–292
K. pneumoniae KP2/FN 265 132–532
LZD 12.7 MSSA/FN 1,292 841–2,787
MEM 62 MSSA/FN 15 8–95
MRSA/FA 6 4–30
MRSA/FN 123 94–179
S. epidermidis/FN 6 4–15
P. aeruginosa/FN 36 23–83
K. pneumoniae KP1/FN 36 21–125
K. pneumoniae KP2/FN 38 26–71
MZ 26 B. fragilis/FN 2 1–2
FEB 163.9 P. aeruginosa/FA 4,141 2,619–9,886
P. aeruginosa/FN 28 26–31
TZP 224 MSSA/FA 288 231–384
MSSA/FN 222 199–251
MRSA/FA 634 478–945
MRSA/FN 590 542–647
S. epidermidis/FA 448 390–526
S. epidermidis/FN 428 383–485
P. aeruginosa/FN 4,692 3,465–7,263
TGC 1.45 S. pneumoniae SP2/FA 14 8–114
S. pneumoniae SP2/FN 32 17–226
K. pneumoniae KP2/FA 32 19–115
K. pneumoniae KP2/FN 32 20–72
VAN 25 E. faecium/FA 221 156–380
E. faecium/FN 120 88–190
S. epidermidis/FA 961 541–1,707
a

Only microorganism-substance combinations for which the TTD was significantly different from control (control data not shown) were used for calculations. Concentrations are rounded to whole numbers.

b

AMC, amoxicillin-clavulanate; CTX, cefotaxime; CIP, ciprofloxacin; FLC, fluconazole; GEN, gentamicin; LZD, linezolid; MEM, meropenem; MZ, metronidazole; FEB, cefepime; TZP, piperacillin-tazobactam; TGC, tigecycline; VAN, vancomycin.